Related Experiment Video
Updated: Sep 13, 2025
09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.6K
Mortality among patients with multiple sclerosis in Poland.
Katarzyna Kapica-Topczewska1, Olga Zajkowska2, Francois Collin3
1Department of Neurology, Medical University of Bialystok, Bialystok, Poland.
Multiple Sclerosis and Related Disorders
|August 3, 2025
Summary
Mortality in multiple sclerosis (MS) patients in Poland is now comparable to the general population. This indicates a significant increase in life expectancy for individuals with MS.
Area of Science:
- Neurology
- Epidemiology
- Public Health
Background:
- Mortality studies in multiple sclerosis (MS) patients are limited.
- Investigating MS mortality trends is crucial for understanding disease impact and healthcare needs.
Purpose of the Study:
- To analyze all-cause mortality in a large cohort of multiple sclerosis patients in Poland.
- To compare MS patient mortality with the general Polish population.
Main Methods:
- Utilized annual mortality data from Statistics Poland for MS patients (2002-2022).
- Employed Standardized Mortality Ratio (SMR) and Excess Death Rates (EDR) for comparative analysis.
- Focused detailed analysis on the 2009-2021 period.
Main Results:
- Recorded 8932 deaths among MS patients between 2002 and 2022.
- Overall SMR and EDR showed a decreasing trend from 2009 to 2021.
- Males and individuals in rural areas exhibited higher SMR and EDR, with decreasing trends over time.
Conclusions:
- Current multiple sclerosis mortality rates in Poland are comparable to the general population.
- This suggests a notable increase in the life expectancy of MS patients.
- Findings highlight improvements in MS patient care and outcomes.
Related Concept Videos
01:21Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
01:24Kaplan-Meier Approach
266
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
266
01:20Actuarial Approach
135
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
135